Så mycket väntas lecanemab sälja globalt

Försäljningen av Leqembi (lecanemab), som nyligen fick ett accelererat USA-godkännande som behandling mot Alzheimers sjukdom, väntas globalt uppgå till sju milj...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Jan Holmgren to receive award for the development of cholera vaccine

Researcher Jan Holmgren is being awarded for the development of the first effective drinkable cholera vaccine. The award is given by the International Vaccine I...

Vaccinpartners på väg att bli rivaler

Franska Valneva och danska Bavarian Nordic, två partners som distribuerat och marknadsfört varandras produkter sedan 2020, kommer snart att bli rivaler inom vac...

Pharmabolag har höjt säkerheten efter vd-mord

Flera stora läkemedelsbolag i USA har förstärkt säkerheten kring sina högsta chefer efter mordet på United Healths vd i december, visar nya dokument.

Kompauto Nordic AB

Merck Life Science A/S

Introducing ZEISS arivis Pro 4.2

Your solution for advanced image analysis and visualization.

Revealing the secrets of a part

CT inspection in automation technology at Festo.

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Meribel Pharma Solna

Study: Semaglutide tablet produces weight loss

The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

Dansk aktör köper krisande amerikanskt cancerbolag

Danska Pharmacosmos tar över det amerikanska läkemedelsbolaget G1 Therapeutics i en affär som uppgår till 405 miljoner dollar.

Reformation eller utbildning? Så kan rovtidskrifterna stoppas

Olika försök har gjorts för att komma till rätta med rovtidskrifterna. Röster höjs för att reformera meriteringssystemet, medan andra lyfter vikten av utbildnin...

Ny mpox-variant sprids från Kongo – ökad efterfrågan på vaccin

En dödligare variant av mpox sprids från Demokratiska Republiken Kongo och utgör en risk för barn. Viruset orsakar feber, huvudvärk, muskelvärk, smärtsamma böld...

Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

Forskaren in Hagastaden now inagurated

The real estate company Vectura's life science center in Hagastaden, Forskaren, is now inaugurated. The opening was attended by people from the industry, politi...

Suing the company – for NOT developing a new HIV drug

Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...

The physician at the tech giant: “Observations in the emergency room made my mind up”

When Nasim Farrokhnia was in third grade at school in Tehran, the capital of Iran, her father gave her a book about Marie Curie, which soon became her favourite...

Novo Nordisk to invest billions in new quality control lab

Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

A mass flow controller that is silent, fast and cost-effective

Portable ventilator breathing devices, bioreactors or the dosing of inert gases all rely on the highest control dynamics. That is exactly what the proportional ...